Mild Cutaneous Reactions to Drugs

Overview

Journal Acta Biomed

Specialty General Medicine

Date 2019 Mar 5

PMID 30830060

Citations 8

Authors

Giuseppe Crisafulli

Fabrizio Franceschini

Silvia Caimmi

Paolo Bottau

Lucia Liotti

Francesca Saretta

Roberto Bernardini

Fabio Cardinale

Francesca Mori

Carlo Caffarelli

Affiliations

Soon will be listed here.

Abstract

Adverse reactions to drugs are not frequent in childhood. Cutaneous reactions are the most frequent in this age group. Mild cutaneous reactions are immediate or delayed adverse reactions that do not seriously compromise the clinical condition of children. The patients usually early improve and recover the state of health. Although it is difficult to define the prevalence accurately, we could affirm that the rate adverse reaction to drugs are often over estimated by both the families and the physicians. Therefore, children may be prone to loss of school days and inappropriate or sub-optimal treatments. However, the identification of a true adverse reaction to drugs allows adequate treatment and alert to further exposure to harmful drugs.

Citing Articles

Diagnosis and Management of Skin Toxicities in Systemic Treatment of Genitourinary Cancers.

Chowdhury D, Chin L, Odabashian R, Fawaz A, Canil C, Ong M Cancers (Basel). 2025; 17(2).

PMID: 39858032 PMC: 11763385. DOI: 10.3390/cancers17020251.

Diffuse Maculopapular Rash: An Uncommon Cutaneous Presentation of Secondary Syphilis.

Hobbs L, Bardhi R, Shah P, Rajabi-Estarabadi A, Akhtar A Cureus. 2024; 16(11):e74087.

PMID: 39712716 PMC: 11661881. DOI: 10.7759/cureus.74087.

DRESS Syndrome That Resembles Graft-Versus-Host Disease after Chemotherapy in a Pediatric Patient: A Case Report.

Rolon M, Barros M, Ortiz C, Cruz Romero S, Alvarez J Case Rep Dermatol. 2024; 16(1):221-225.

PMID: 39473560 PMC: 11521526. DOI: 10.1159/000541046.

Chlorzoxazone-Induced Fixed Drug Eruption: A Clinical Case Report.

Alotaibi H, Alsergani R, Alharbi A, Nabil Nagshabandi K, Almubark A Int Med Case Rep J. 2024; 17:771-775.

PMID: 39253615 PMC: 11382667. DOI: 10.2147/IMCRJ.S480653.

Why drug exposure is frequently associated with T-cell mediated cutaneous hypersensitivity reactions.

Line J, Saville E, Meng X, Naisbitt D Front Toxicol. 2023; 5:1268107.

PMID: 37795379 PMC: 10546197. DOI: 10.3389/ftox.2023.1268107.

References

Vassileva S, Mateev G, Parish L . Antimicrobial photosensitive reactions. Arch Intern Med. 1998; 158(18):1993-2000. DOI: 10.1001/archinte.158.18.1993. View

Kowalski M, Woessner K, Sanak M . Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema. J Allergy Clin Immunol. 2015; 136(2):245-51. DOI: 10.1016/j.jaci.2015.06.021. View

Monteiro A, Rato M, Martins C . Drug-induced photosensitivity: Photoallergic and phototoxic reactions. Clin Dermatol. 2016; 34(5):571-81. DOI: 10.1016/j.clindermatol.2016.05.006. View

Colton R, Amir J, Mimouni M, Zeharia A . Serum sickness-like reaction associated with griseofulvin. Ann Pharmacother. 2004; 38(4):609-11. DOI: 10.1345/aph.1D291. View

Vial T, Pont J, Pham E, Rabilloud M, Descotes J . Cefaclor-associated serum sickness-like disease: eight cases and review of the literature. Ann Pharmacother. 1992; 26(7-8):910-4. DOI: 10.1177/106002809202600708. View

Katta R, Anusuri V . Serum sickness-like reaction to cefuroxime: a case report and review of the literature. J Drugs Dermatol. 2007; 6(7):747-8. View

Ozkaya-Bayazit E . Specific site involvement in fixed drug eruption. J Am Acad Dermatol. 2003; 49(6):1003-7. DOI: 10.1016/s0190-9622(03)01588-3. View

Caffarelli C, Cuomo B, Cardinale F, Barberi S, Dascola C, Agostinis F . Aetiological factors associated with chronic urticaria in children: a systematic review. Acta Derm Venereol. 2012; 93(3):268-72. DOI: 10.2340/00015555-1511. View

Caffarelli C, Dondi A, Dascola C, Ricci G . Skin prick test to foods in childhood atopic eczema: pros and cons. Ital J Pediatr. 2013; 39:48. PMC: 3734168. DOI: 10.1186/1824-7288-39-48. View

10.

Staevska M, Gugutkova M, Lazarova C, Kralimarkova T, Dimitrov V, Zuberbier T . Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial. Br J Dermatol. 2014; 171(1):148-54. PMC: 4232862. DOI: 10.1111/bjd.12846. View

11.

Selvaag E . Clinical drug photosensitivity. A retrospective analysis of reports to the Norwegian Adverse Drug Reactions Committee from the years 1970-1994. Photodermatol Photoimmunol Photomed. 1997; 13(1-2):21-3. DOI: 10.1111/j.1600-0781.1997.tb00103.x. View

12.

Naranjo C, Busto U, Sellers E, Sandor P, Ruiz I, Roberts E . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30(2):239-45. DOI: 10.1038/clpt.1981.154. View

13.

Caffarelli C, Rico S, Rinaldi L, Dascola C, Terzi C, Bernasconi S . Blood pressure monitoring in children undergoing food challenge: association with anaphylaxis. Ann Allergy Asthma Immunol. 2012; 108(4):285-6. DOI: 10.1016/j.anai.2012.02.001. View

14.

Lee A . Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years. Contact Dermatitis. 1998; 38(5):258-60. DOI: 10.1111/j.1600-0536.1998.tb05739.x. View

15.

Mizukawa Y, Yamazaki Y, Shiohara T . In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption. Br J Dermatol. 2008; 158(6):1230-8. DOI: 10.1111/j.1365-2133.2008.08516.x. View

16.

. Harmonizing the use of adverse-drug reaction terms. Definitions of terms and minimum requirements for their use: respiratory disorders and skin disorders. Pharmacoepidemiol Drug Saf. 1997; 6(2):115-27. DOI: 10.1002/(SICI)1099-1557(199703)6:2<115::AID-PDS252>3.0.CO;2-X. View

17.

Shiohara T . Fixed drug eruption: pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol. 2009; 9(4):316-21. DOI: 10.1097/ACI.0b013e32832cda4c. View

18.

Grosen A, Julsgaard M, Christensen L . Serum sickness-like reaction due to Infliximab reintroduction during pregnancy. J Crohns Colitis. 2012; 7(5):e191. DOI: 10.1016/j.crohns.2012.10.006. View

19.

Dreyfus D, Randolph C . Characterization of an anaphylactoid reaction to omalizumab. Ann Allergy Asthma Immunol. 2006; 96(4):624-7. DOI: 10.1016/S1081-1206(10)63560-0. View

20.

Nettis E, Marcandrea M, Maggio G, Ferrannini A, Tursi A . Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients. Immunopharmacol Immunotoxicol. 2002; 23(4):585-95. DOI: 10.1081/iph-100108604. View